Home › Therapeutic areas › Renal › Polycystic Kidney Disease
Polycystic Kidney Disease (2 companies)
Companies with an active program in Polycystic Kidney Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ELOX | Eloxx Pharmaceuticals | DermatologyRenal Rare | 1 | Phase 2 | $50.2M | 4 |
| SCYX | Scynexis | Infectious DiseaseRenal Rare | 1 | Approved | $34.8M | 5 |
No companies match.